-
May 7: The Week in Cancer News
A Food and Drug Administration panel recommends withdrawing approvals for two treatment indications for immunotherapy drugs, and the U.S. Preventive Services Task Force recommend against vitamin E and beta-carotene for cancer prevention.
by Kevin McLaughlin
-
April 16: The Week in Cancer News
Studies presented at the AACR Annual Meeting 2021 shed light on treatment of a variety of cancers, and articles discuss the risks of COVID-19 for people who have been vaccinated but are immunocompromised.
by Kate Yandell
-
Coverage of the AACR Annual Meeting 2021
This year's AACR Annual Meeting features the latest advances in basic, translational and clinical cancer research. The more than 13,000 attendees at the virtual event represent more than 70 countries.
by Kevin McLaughlin
-
April 9: The Week in Cancer News
A nationwide campaign encourages Americans to get their cancer screenings, and a study reports improved outcomes for patients taking oral cancer drugs when they have professional oversight.
by Kevin McLaughlin
-
April 2: The Week in Cancer News
A study indicates that people are delaying medical care until they are eligible for Medicare, leading to missed cancers, and the Food and Drug Administration approves the first CAR-T cell therapy for multiple myeloma.
by Kate Yandell
-
March 19: The Week in Cancer News
A study indicates breast cancer centers often recommend earlier and more frequent screening than national guidelines, and experts ponder COVID-19 vaccines' role is quelling the evolution of concerning viral variants in people with weakened immune systems.
by Marci A. Landsmann
-
March 12: The Week in Cancer News
Lung cancer screening recommendations expand to include more smokers, and a U.K. study finds cancer patients may be less protected from COVID-19 than people without cancer after the first dose of the Pfizer-BioNTech vaccine.
by Kevin McLaughlin
-
March 5: The Week in Cancer News
A patient advocate and researcher argue that the U.S. has set insufficiently ambitious cervical cancer screening goals, and Merck withdraws the small cell lung cancer indication for its immunotherapy drug Keytruda.
by Kate Yandell
-
Survival Statistics 101
Survival statistics are important—and sometimes confusing. Cancer Today spoke with statistics experts about what these numbers really mean.
by Ashley P. Taylor
-
February 19: The Week in Cancer News
Organizations call to prioritize cancer patients for COVID-19 vaccination, researchers analyze rates of “low-value” breast surgeries, and UCLA cancer survivors write letters to patients undergoing treatment.
by Marci A. Landsmann
Cancer Talk
Cancer Today Editors’ Picks: 2024
Our favorite Cancer Today stories from 2024, as picked by the editors.
Rethinking the Role of RadiationChest radiation may not be necessary for people with intermediate-risk breast cancer.
by Thomas Celona
De-escalating Treatment for DCISResearch finds certain people with low-risk DCIS may be able to forgo surgery or radiation.
by Thomas Celona
Study Highlights Challenges in Pancreatic Cancer StagingMost pancreatic ductal adenocarcinoma cases initially considered to be stage I are changed to a higher stage after surgery.
by Taneia Surles